Additional Coverage:
- Chris Evert says Jannik Sinner ‘shouldn’t have been allowed’ to leave court during French Open controversy (foxnews.com)
Tennis icon Chris Evert has weighed in on the recent medical timeout controversy involving top-ranked Jannik Sinner, highlighting the delicate balance between protecting star players and upholding the sport’s rules.
Evert, an 18-time Grand Slam singles champion, acknowledges that tennis’ biggest names like Sinner, Carlos Alcaraz, Novak Djokovic, and others are vital to the sport’s popularity and business. “The top players still drive the game,” she told OutKick.
“If tennis wants its stars to have longevity, there should be more consideration of their schedule in a two-week event. They’ve earned that.”
However, Evert draws a firm line when it comes to how medical timeouts are applied during matches. She criticized the decision to allow Sinner to leave the court during his recent French Open match, citing the clear rule that muscle cramping does not qualify for a medical timeout.
“It was clearly cramping and dehydration,” she said. “The rules state cramping is not an injury.
He shouldn’t have been allowed to go off the court.”
Sinner’s dramatic second-round loss to Juan Manuel Cerundolo was marked by a physical collapse after leading comfortably. Importantly, the controversy isn’t about favoritism helping a star win-Sinner ultimately lost-but about whether rules are enforced equally regardless of player status.
TNT commentator Jim Courier echoed this concern live on air: “We love the top players, they drive the sport, but you’ve gotta apply the rules fairly. The rules are being bent for the top players.”
Evert also emphasized that Sinner is not to blame for the situation, noting the choice was made by the chair umpire after Sinner expressed feeling unwell. According to reports, Sinner asked what would happen if he took extra time between points, and the umpire laid out the options, leaving the decision to him.
“No serious athlete is going to refuse medical attention when they’re struggling,” Evert said. “The umpire made the call, and Sinner acted accordingly.”
This incident highlights the tricky gray area tennis faces when distinguishing between legitimate medical issues and rule enforcement. While the rulebook is clear on cramps, it also allows for medical discretion in cases of heat illness or dizziness. Player safety is paramount, but transparency and consistency are essential to maintain trust.
Evert suggests a sensible approach: if a player is dizzy or at risk of fainting, medical staff should assess and clearly communicate the reason for treatment. If it’s only cramping, the rules should be enforced as written.
This isn’t the first time such debates have arisen. At the 2026 Australian Open, similar situations involving Sinner and Alcaraz sparked complaints about medical timeouts for cramping. Yet, officials followed tournament rules, which can sometimes favor marquee players due to their impact on the sport.
These controversies mirror issues in other sports, like the NFL, where star players often benefit from favorable calls-whether perceived or real-because their presence is critical to the game’s appeal.
Ultimately, Evert’s point is clear: top players deserve scheduling and recovery considerations because they carry the sport’s profile. But they should not receive a different interpretation of the rules during matches simply because of their star power.
For tennis to avoid future disputes, the boundaries around medical timeouts need to be clarified and consistently enforced. Stars should continue to enjoy prime courts and prime time, but the rulebook must apply equally to all competitors.
As Evert concludes, “They’ve earned the big moments. What they haven’t earned is a different version of the rulebook.”